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Abstract
 .In this study we investigated the transepithelial transport of Ochratoxin A OTA , a potent nephrotoxin, across
  .monolayers of two collecting duct-derived cells clones Madin-Darby canine kidney cells MDCK -C7 and MDCK-C11
.cells, resembling principal and intercalated cells, respectively either from the apical to the basolateral side or vice versa.
 .We cultured cells on permeable supports and compared the transport rates of OTA, p-aminohippuric acid PAH and
fluorescein-labelled inulin. Monolayers of both cell clones translocated OTA from the apical to the basolateral side but not
in the opposite direction. Transport rate across MDCK-C11 cell monolayers was 2.9-fold the transport rate across
MDCK-C7 cell monolayers. OTA transport was temperature-dependent being reduced from 77.5 pmolrcm2 per h to 10.1
pmolrcm2 per h in MDCK-C11 and from 27.0 pmolrcm2 per h to 7.6 pmolrcm2 per h in MDCK-C7 cells when
temperature was decreased from 378C to 48C. In both cell clones, the dipeptides carnosine and glycylsarcosine but not the
amino acids glycine or phenylalanine had an inhibitory effect on OTA transport. In both cell clones, transepithelial transport
 .of OTA was dependent on the apical pH pK of OTAs7.1 . In an environment mimicking the transepithelial in vivo pHa
gradient to some extent with more acidic pH on the apical side than on the basolateral side, transport was 4-fold higher in
both cell clones as compared to conditions when pH was 7.4 in both bath solutions. In the absence of a pH gradient,
w3 xtransport rates were similar to that at 48C. Apical uptake of H OTA was inhibited by carnosine and by glycylsarcosine and
w3 xthe uptake of H carnosine was inhibited by OTA. Our results indicate that OTA is transported across the apical membrane
of MDCK cells by both non-ionic diffusion and by a Hq-dipeptide cotransporter. Thus, reabsorption of OTA in the
collecting duct contributes to the observed long half life of OTA in the mammalian body.
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1. Introduction
Ochratoxin A is a potent nephrotoxic agent pro-
duced by several fungi of Aspergillus and Penicil-
lium species. Via contaminated animal feed and hu-
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w xman food it also threatens human health 1–4 . OTA
is bound to albumin and to so far unknown small
w xproteins in the blood to more than 99% 5,6 and it
remains in the body for long times up to 510 h in
w x.apes 7 . Porcine Nephropathy and perhaps also
Balkan Endemic Nephropathy are visible damages
w xcaused by OTA in man and animals 8–12 . In the
w xkidney proximal parts of the nephron 13–15 and
also postproximal parts are affected by OTA where it
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blocks plasma membrane anion conductance and de-
w xranges pH homeostasis 16,17 .
In the kidney, proton-coupled transporters of
woligopeptides have been described and cloned 18–
x20 . They transport also dipeptide-mimicking
w xmolecules like b-lactam antibiotics 21,22 . OTA
consists of a 7-carboxy-5-chloro-8-hydroxy-3,4-dihy-
dro-3R-methylisocoumarin linked over its carboxy
w xgroup to L-b-phenylalanine 23 and is thus similar to
dipeptides. Therefore, peptide carriers might play a
role in apical OTA transport leading to its reabsorp-
tion from the collecting duct. Because reabsorption of
OTA in these postproximal sections could contribute
to OTA’s long half life in the body, we used two cell
clones, MDCK-C7 and MDCK-C11 cells, resembling
principal and intercalated cells of the collecting duct
which have been isolated recently in our laboratory
w xfrom the MDCK cell wildtype 24 to investigate
transport of OTA across renal epithelial cell mono-
layers.
2. Materials and methods
2.1. Cell culture
Madin-Darby canine kidney cells MDCK-C7 and
w x .MDCK-C11 cells 24 , passage 65–80 were cultured
w xas described 17 in MEM medium, pH 7.4, supple-
mented with Earl’s salts, non-essential amino acids,
10% fetal calf serum Biochrom KG, 12213 Berlin,
.FRG , and 26 mmolrl NaHCO at 378C and 5%3
CO . For transport studies, cells were seeded on2
 2permeable supports membrane filters, 4.9 cm , Fal-
.con, Becton-Dickinson, 69006 Heidelberg, FRG and
incubated for three days in the above mentioned
medium until they had reached confluence. Further-
more, confluence of the cell monolayer was con-
firmed by measuring the transepithelial electrical re-
sistance with a voltohmmeter EVON, WPI, Sarasota,
USA, MDCK-C7 cells 794.3"129.2 V=cm2, ns
32 and MDCK-C11 cells 319.1"33.2 V=cm2, n
.s32, remaining stable during the experiment .
2.2. Transepithelial transport studies
For transport studies, the medium was exchanged
 against Hepes-Ringer buffer in mmolrl: Hepes N-
 . X .2-hydroxyethyl piperazine-N -2-ethane sulfonic acid
10, NaCl 122.5, KCl 5.4, MgCl 0.8, CaCl 1.2,2 2
.NaH PO 1, glucose 5.5 . Medium volumes were 1.32 4
ml apical and 2.5 ml basolateral. The pH was individ-
ually adjusted for each experiment, usually, in the
basolateral bath pH was 7.4, apical either 7.4 or 6.0.
 .  .OTA usually 5 mmolrl , PAH 5 mmolrl and
 . fluorescein isothiocyanate FITC -Inulin 100
.mgrml were added either to the apical or the baso-
lateral bath solution as indicated for each experiment.
The experiments were performed either at 378C or at
48C in room atmosphere. If not stated otherwise, the
OTA-free bath solution was exchanged completely
against fresh bath solution every 30 min for the first
2 h. The last sample was taken after additional 2 h of
incubation.
OTA and PAH content in the removed bath solu-
tion was determined by HPLC as described below.
FITC-Inulin was determined by fluorometric detec-
tion at an excitation wavelength of 480 nm and an
emission wavelength of 520 nm. The relative amount
of OTA transported that exceeds the relative amount
of transported PAH represents transcellular transport
under the assumption that MDCK cells do not ex-
press the organic anion carrier.
2.3. Determination of intracellular OTA content
After incubation, cells were rapidly washed six
times with ice-cold phosphate buffered saline PBS-
buffer, in mmolrl: NaCl 141, KCl 4, MgCl 1,2
CaCl 1, NaH PO 0.4, Na HPO 1.6, glucose 5, pH2 2 4 2 4
.7.4 . Cells were opened by adding 0.1% Triton X-100
to the buffer, and after 15 min incubation at room
temperature lysed cells were collected in a centrifuge
 .cap. After centrifugation at 8000=g 10 min the
protein in the supernatant was precipitated with three
volumes ethanol. This ethanol treatment completely
removes OTA from the protein and leads to 99%
recovery of OTA in the supernatant as shown previ-
w xously in our laboratory 25 . After final centrifugation
 .8000=g, 10 min , the supernatant was vacuum
dried, and the OTA content was determined by HPLC
as described below.
2.4. HPLC
OTA was determined under isocratic conditions
using a reverse phase C-18 column Nova Pak C18,
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150=3.9 mm, Millipore Waters GmbH, 65731 Es-
.chborn, FRG and subsequent fluorometric detection
 .RF-551, Shimadzu, Japan at an excitation wave-
length of 330 nm and an emission wavelength of 460
w xnm. The flow rate was 1 mlrmin. According to 3
the mobile phase consisted of acetonitrile 45%, Pro-
. mochem, 46469 Wesel, FRG , deionized water 53%,
.Seral, 56235 Ransbach-Baumbach, FRG and glacial
 .acetic acid 2%, Merck, 64271 Darmstadt, FRG .
Under these conditions the solvent peak appeared 1.3
min, the peak of OTa , a metabolite of OTA, 2.8 min,
and the peak of OTA 4.5 min after injection.
PAH was determined under isocratic conditions
using a reverse phase C-18 column Spherisorb-
5ODS, 25=0.46 cm, particle size 5 mm, Kontron,
.85386 Eching, FRG and subsequent photometric
detection at 235 nm Kontron UV spectrophotom-
.eter . The flow rate was 1.3 mlrmin, the mobile
phase consisted of 20% acetonitrile, deionized water
and 0.8% glacial acetic acid. PAH absorbance could
be detected 3.5 min after injection.
2.5. Apical uptake experiments and determination of
intracellular radioacti˝ity
Experiments were done three days after seeding in
24-well dishes with an established confluent cell
monolayer. The medium was exchanged against
Hepes-Ringer buffer pH 6.0. The concentration of
w3 x  .H OTA was 84 nmolrl 137 TBqrmol , the con-
w14 xcentration of methoxy C inulin, which served as
extracellular control substance, was 0.73 mmolrl
 .2.11 TBqrmol . After the experiment, cells were
washed immediatly with ice-cold PBS buffer. Cells
were detached by 60 minutes incubation with 0.1%
trypsin solution in PBS containing 0.02% EDTA and
collected in a scintillation tube. 4 ml scintillation
 .fluid Packard, Meriden, USA were added and ra-
dioactivity was determined in a Packard Liquid Scin-
 .tillation Analyzer Packard, Meriden, USA .
2.6. Enzyme assay and protein- and cell ˝olume
determination
Lactate dehydrogenase activity in the buffer or in
Triton-X 100-lysed cells were measured according to
w x26 at room temperature in a photometer. Protein
w xwas determined according to 27 . Cell volume was
calculated as follows: The average number of cells on
 2. 6  .one filter 4.9 cm was 2.5P10 cells ns7 . Cell
volume was determined to 2.2 plrcell by a cell
counter and analysis system Coulter counter, Scharfe¨
.System, 72770 Reutlingen, FRG . This gives a total
cell volume of 5.5 mlrfilter and 1.61 ml per well
 2.1.43 cm .
2.7. Chemicals
Crystalline OTA was purchased from Sigma St.
. w3 xLouis, USA . H OTA was purchased from Moravek
w14 xBiochemicals, Brea, USA. Methoxy C inulin was
purchased from DuPont NEN, Bad Homberg, FRG.
w 3 xCarnosine, L- b-alanine-3- H , was purchased from
American Radiolabeled Chemicals, St. Louis, USA.
All other chemicals were obtained from Merck 64271
.Darmstadt, FRG .
2.8. Statistics
All measurements are given as mean values"S.E.
The significance of difference was determined by the
unpaired Student’s t-test. P-0.05 was considered to
be statistically significant.
3. Results
3.1. Viability of cells after OTA treatment
For initial control, we incubated MDCK-C7 and
MDCK-C11 cells with 5 mmolrl OTA for 4 h in
Hepes-Ringer buffer pH 6.0 and measured the lactate
 .dehydrogenase LDH activity in the buffer and in-
side the cells as an indicator of the extent of cytoly-
sis. Only 0.81% of the total LDH-activity could be
detected in the medium of MDCK-C11 cells after 4 h
 .incubation 0.82% in MDCK-C7 cells . Control cells
incubated without OTA showed 0.96% and 0.79%
LDH-activity in the media of MDCK-C11 and
 .MDCK-C7 cells, respectively ns3 . This shows
that during the 4 h experiment the viability of the
cells is not impaired by OTA.
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 .Fig. 1. Transepithelial transport of ochratoxin A OTA and
 .p-aminohippurate PAH from the apical to the basolateral side
and vice versa in MDCK-C11 cells. Transport was studied at pH
 .6.0 apically and pH 7.4 basolaterally apical to basolateral or at
 .pH 7.4 apically and pH 6.0 basolaterally basolateral to apical at
 .378C for 4 h. Inset shows transport of PAH ns6 . 5 mmolrl
OTA and 5 mmolrl PAH were added apically or basolaterally,
and the respective opposite bath solution was exchanged every 30
min. The amounts of transported substances in the respective
opposite bath solution were summed up. Values are given as
percent of apically or basolaterally added amount of substances.
The number of filters is shown in brackets. ))) indicates a
P -0.001 compared to basolateral to apical transport.
3.2. Transepithelial OTA transport in MDCK-C11
cells
3.2.1. Reabsorpti˝e transepithelial OTA transport in
MDCK-C11 cells
After 4 h incubation 309"29.8 pmolrcm2 OTA
 .were transported from the apical pH 6.0 to the
 .  .basolateral pH 7.4 bath ns15 . This corresponds
to 23.4% of OTA added to the apical bath. However,
 .if OTA was added to the basolateral pH 6.0 side,
only 72.1"4.0 pmolrcm2 OTA were transported to
 .the apical pH 7.4 side during 4 h incubation, corre-
 .sponding to 5.4% of added OTA ns12, Fig. 1 .
Thus, transcellular transport of OTA occurs only
from the apical to the basolateral compartment. In
contrast, PAH transport was equal in both directions
 .1.09% and 1.08% of added PAH, respectively . The
directional OTA transport also excludes a transport
via tight junctions of the cell. However, if OTA was
added simultaneously in equal concentrations 5
.mmolrl to both sides of the epithelium, no accumu-
lation of OTA in one of both bath solutions could be
 .detected after 4 h of incubation at 378C not shown .
Thus, the cell layer was not able to establish a
transepithelial OTA concentration gradient.
3.2.2. pH dependence of transepithelial OTA trans-
port in MDCK-C11 cells
OTA transport was clearly dependent on the apical
pH. When pH was raised from 6.0 to 7.4 on the
apical side, only 65.1"19.3 pmolrcm2 per 4 h were
 .transported to the basolateral bath pH 7.4 compared
2  .to 309"29.8 pmolrcm per 4 h at pH 6.0 ns9 .
However, PAH and FITC-Inulin transport were inde-
 .pendent of pH Fig. 2 .
3.2.3. Temperature dependence of transepithelial OTA
transport in MDCK-C11 cells
309"29.8 pmolrcm2 OTA, corresponding to
23.4% of OTA added to the apical bath solution were
Fig. 2. pH-dependent transepithelial transport of ochratoxin A
 .  .  .OTA , p-aminohippurate PAH and FITC-Inulin FITC in
MDCK-C11 cells. 5 mmolrl OTA, 5 mmolrl PAH, and 100
mgrl FITC-Inulin were added apically. Transport from the apical
to the basolateral bath was studied at 378C at an apical pH of 6.0
or pH 7.4 for 4 h. Basolateral pH was 7.4 in both experiments.
Basolateral bath solution was exchanged every 30 min and the
amounts of the respective transported substances in the basolat-
eral bath were summed up. Values are given as percent of
apically added chemicals. ))) indicates a P -0.001 compared
to pH 7.4. The number of filters is shown in brackets.
( )G. Schwerdt et al.rBiochimica et Biophysica Acta 1324 1997 191–199 195
Fig. 3. Temperature dependence of cumulative transepithelial
 .  .transport of ochratoxin A OTA , p-aminohippurate PAH and
 .FITC-Inulin FITC from the apical to the basolateral bath solu-
tion in MDCK-C11 cells after 4 h incubation. Apical pH was 6.0
and basolateral pH 7.4. 5 mmolrl OTA, 5 mmolrl PAH, and
100 mgrl FITC-Inulin were added apically, and the basolateral
bath solution was exchanged every 30 min. The amounts of
transported substances in each sample of one filter were summed
up. Values are given as percent of apically added substances.
))) indicates a P -0.001 compared to 48C, aaa indicates a
P -0.001 compared to the PAH transport, number of filters in
 .brackets. Inset shows time course of OTA v and PAH trans-
 .port B .
transported to the basolateral side within 4 h at 378C
 .and pH 6.0 ns15 . This corresponds to 86.5% of
the OTA-flux measured on uncolonized control filters
during 4 h incubation and demonstrates the high
capacity of the transport systems involved. Only 39.4
"5.5 pmolrcm2 per 4 h of OTA corresponding to
2.97% of the added amount were transported at a
 .temperature of 48C ns6, Fig. 3 . Thus, at 48C OTA
transport was reduced to 12.7% as compared to that
at 378C. This shows that transepithelial OTA trans-
port needs cellular activity and is not only a simple
diffusion process. However, even at 378C the PAH-
and the FITC-Inulin content in the basolateral bath
solution was virtually nil although PAH has only half
the molecular weight of OTA. But the relative amount
of transported OTA at 48C is still higher than the
relative amount of PAH transported at 378C. The low
amount of PAH and FITC-Inulin transported again
proves the tightness of the cell monolayer during the
experiment.
3.3. Transepithelial OTA transport in MDCK-C7 cells
3.3.1. Reabsorpti˝e, pH- and temperature-dependent
transepithelial OTA transport in MDCK-C7 cells
MDCK-C7 cell monolayers also transported OTA
in a pH- and temperature-dependent manner. Further-
more, only apical to basolateral transport could be
detected as already shown for the MDCK-C11 cells.
When OTA was added to the basolateral side instead
of the apical side, only 0.4% of OTA added to the
basolateral side were translocated to the apical side
 2after 4 h incubation which represents 54.8 fmolrcm ,
.Fig. 4 . Transport from the apical to the basolateral
bath under optimal conditions pH 6.0 apically and
. 2378C was 108.1 pmolrcm after 4 h incubation
 .corresponding to 8.2% of added OTA ns15 and
was less than that observed for MDCK-C11 cells. At
 .low temperature 48C , only 2.3% of added OTA
 2 .were transported after 4 h 29.8 pmolrcm , ns9 .
 .Fig. 4. Transepithelial transport of ochratoxin A OTA and
 .p-aminohippurate PAH from the apical to the basolateral bath
and vice versa in MDCK-C7 cells. Transport was studied at pH
6.0 apically and pH 7.4 basolaterally at 378C for 4 h. OTA 5
.  .mmolrl and PAH 5 mmolrl were added apically or basolater-
ally and the respective opposite bath solution was exchanged
every 30 min. Transported amounts of OTA or PAH, respec-
tively, in the opposite bath were summed up. Values are given as
percent of apically or basolaterally added substances. The number
of filters is shown in brackets. ))) indicates a P -0.001
compared to basolateral to apical OTA transport, ) indicates a
P -0.05 compared to basolateral to apical PAH transport.
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 . Fig. 5. Intracellular ochratoxin A OTA concentration mmolrl
.cell volume after 4 h incubation in MDCK-C11 cells. The pH of
the apical bath was either 6.0 or 7.4. 3.5 mmolrl OTA horizon-
.  .  .tal line were added to the apical ap or basolateral bas bath
and after 4 h the cells were washed and opened with Triton
X-100 and OTA determined. bassbasolateral, apsapical.
Number of samples in brackets. ))) indicates a P -0.001
compared to pH 7.4 and )) indicates a P -0.005 compared to
pH 7.4.
3.4. Intracellular OTA concentration
In MDCK-C7 and MDCK-C11 cells, intracellular
 .OTA concentration mmolrl cell volume after 4 h
incubation was dependent on temperature, pH and on
the side to which OTA was added. If OTA was added
apically, equimolarity of intracellular OTA with that
in the apical bath solution could be detected only at
 .48C 3.5 mmolrl , whereas at 378C the intracellular
OTA concentration was significantly lower than that
 .in the apical bath 1.06 mmolrl, Fig. 5 . However, if
OTA was present on the basolateral side, also at 378C
intracellular OTA concentration was equal to the
 .basolateral OTA concentration 3.5 mmolrl al-
though virtually no OTA could be detected in the
apical bath solution under these conditions as de-
scribed above. Additionally, at an apical pH of 6.0,
more OTA could be detected inside the cells as
compared to pH 7.4.
3.5. Inhibition of transepithelial OTA transport by
apically added dipeptides in MDCK-C7 and MDCK-
C11 cells
Because of the phenylalanine moiety and the pep-
tide bond of OTA, and the pH dependence of trans-
port, a Hq-dipeptide cotransporter might be involved
Fig. 6. Effect of dipeptides and amino acids on transepithelial
 .  .OTA transport. A MDCK-C11 cells. B MDCK-C7 cells. Note
the different scales of the ordinates. Transport was studied at pH
6.0 apically and pH 7.4 basolaterally and at 378C for 4 h.
Basolateral bath solution was exchanged every 30 min. Dipep-
 .tides carnosine 5 mmolrl, glycylsarcosine 50 mmolrl or amino
 .  .acids 5 mmolrl and OTA 5 mmolrl were added apically and
the amount of transported OTA was determined in the basolateral
bath and summed up. ))) indicates a P -0.001 compared to
control and ) indicates a P -0.05 compared to control.
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w xin the apical uptake of OTA into the cell 28 . To
prove this, we studied transport of OTA in the pres-
ence of the dipeptides glycylsarcosine and carnosine
at pH 6.0 apically. In both cell clones studied, carno-
sine and glycylsarcosine inhibited OTA transport sig-
 .nificantly Fig. 6 . Carnosine was a more potent
inhibitor than glycylsarcosine. In the presence of 5
mmolrl carnosine transport was reduced from 309.9
pmolrcm2 per 4 h to 103.25 pmolrcm2 per 4 h in
 . 2MDCK-C11 cells ns9 and from 108.1 pmolrcm
per 4 h to 34.9 pmolrcm2 per 4 h in MDCK-C7 cells
 .ns7 whereas in the presence of 50 mmolrl gly-
cylsarcosine transport was reduced to 237.1
pmolrcm2 per 4 h in MDCK-C11 cells and to 84.2
pmolrcm2 per 4 h in MDCK-C7 cells. The single
 .amino acids phenylalanine or glycine 5 mmolrl had
 .no effect on OTA transport Fig. 6 .
[3 ]3.6. Apical uptake of H OTA by MDCK-C11 cells
w3 xThe time course of H OTA uptake showed that
w3 xthe intracellular H OTA content reached its maxi-
mum after 30 min incubation at pH 6.0 and 378C 15
min: 937.9"11.8 pmolrml cell volume; 30 min:
1932"20.8 pmolrml cell volume and 60 min: 2072
."31.4 pmolrml cell volume, ns4 . OTA uptake
was linear in the concentration range tested up to
.250 mmolrl OTA . After 30 min incubation at 378C
w3 xand pH 6.0, uptake of H OTA was inhibited by 5
mmolrl carnosine from 64.1"0.8 pmolrmin per ml
cell volume to 36.6"1.4 pmolrmin per ml cell
 .volume ns4; P-0.01 and by 5 mmolrl glycyl-
sarcosine to 50.5"2.7 pmolrmin per ml cell volume
 .ns4; P-0.05 corresponding to a decrease to
57.6% and 79.3% of maximal uptake, respectively.
3 The uptake of H-labelled carnosine 19.7"0.46
fmolrmin per ml cell volume, ns4; 5 nmolrl
.solution, 1480 TBqrmol into MDCK-C11 cells was
inhibited by 100 mmolrl OTA to 14.1"1.51
fmolrmin per ml cell volume, corresponding to
.71.5% of maximal uptake; ns4, P-0.001 and by
50 mmolrl glycylsarcosine or carnosine to 9.4"
0.92 and 9.5"0.36 fmolrmin per ml cell volume,
corresponding to 29.5% and 30.0% of maximal up-
.take, respectively, ns4; P-0.001 after 30 min
incubation. This shows that OTA interacts with a
dipeptide uptake system in the apical cell membrane.
4. Discussion
The toxic effects of OTA are at least in part
enhanced by its unusual long presence in the mam-
w xmalian body 7 . Besides its strong binding to plasma
w xproteins such as albumin 5,6 , which prevents an
effective filtration in the kidney, a reabsorptive up-
take of OTA along the nephron may additionally
increase its persistence in the body and thus intensify
its toxicity. For this reason, and as earlier studies of
our laboratory showed that the function of the collect-
w xing duct is highly affected by OTA 16,17 we stud-
ied the transport of OTA in cells derived from the
collecting duct MDCK-C7 and MDCK-C11 resem-
bling principal and intercalated cells of the collecting
w x.duct, respectively 24 , in order to uncover such
transport capabilities. We found a clear pH- and
temperature-dependent transepithelial transport of
OTA which occurs only from the apical to the baso-
lateral side but not vice versa proving that collecting
duct cells are able to ‘reabsorb’ OTA.
In both cell clones, transepithelial OTA transport
was temperature-dependent. At 48C, the transport rate
in MDCK-C11 and MDCK-C7 cells was significantly
reduced to 12.6% and to 27.6% resp. of the transport
rate observed at 378C. However, at 48C intracellular
OTA concentration was increased as compared to
378C and even equalled the apical OTA concentration
whereas at 378C, significantly less OTA was detected
inside the cell. This suggests that an additional car-
rier-mediated, temperature-dependent and thus active
process is located at the basolateral side of the cell.
At 378C the carrier extrudes OTA across the basolat-
eral membrane keeping the intracellular concentration
low. In contrast, at 48C and thus with low cellular
activity OTA enters the cell at the apical side pas-
sively but is prevented from leaving the cell across
the basolateral membrane.
The dependence of the cellular OTA concentration
on temperature and the side of OTA exposure sug-
gests that the apical membrane acts as a valve which
allows the entry but not the exit of any OTA across
the apical membrane. The only way for OTA to leave
the cell via the basolateral membrane is a tempera-
ture-dependent process and is the rate limiting step.
This is in good accordance to findings in the human
intestinal Caco-2 cell line where the export of glycyl-
sarcosine across the basolateral membrane limits its
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w xtransepithelial transport 29 . Unfortunately, only lit-
tle is known about basolateral exit of oligopeptides
w x30 . It has been suggested that, in the intestine,
basolateral export is a proton-peptide symport but
different from the proton-dipeptide cotransport at the
w xapical membrane 31,32 . However, in MDCK cells
net transport did not occur if the basolateral bath has
the same OTA concentration as the apical bath. This
shows that basolateral OTA transport is facilitated
diffusion and thus is not able to establish a concentra-
tion gradient. In the blood, however, albumin and
w xother plasma constituents 5,6 can act as a binding
sink for OTA so that in vivo a constant drag for OTA
out of the cell into the blood exists.
The phenylalanine moiety of OTA leads to an
interaction of OTA with phenylalanine-handling pro-
teins such as phenylalanyl-tRNA synthetase or
w xphenylalanine hydroxylase 33,34 . Proton-coupled
oligopeptide cotransporter not only transport dipep-
 .tides e.g. carnosine but also similar molecules such
w xas b-lactam antibiotics 22,35,36 . As OTA consists
of an isocoumarin ring linked to phenylalanine by a
peptide bond it is possible that OTA is a substrate of
q w xan apical H -peptide cotransporter 28,30,37 . The
presence of a Hq-dipeptide cotransport system with a
K of 1.3 mM in MDCK-cells has been describedm
w xrecently 38 . In that study, uptake of dipeptides was
pH-dependent as was the transport of OTA in the
 .present study. Our results which show that i OTA
transport through MDCK-C11 and MDCK-C7 cell
monolayers was not inhibited by single amino acids
but by the dipeptides carnosine or glycylsarcosine;
 . w3 xii that both dipeptides inhibit H OTA entry into
 .the cell across the apical membrane and iii that
w3 xOTA inhibits H carnosine uptake point to the in-
volvement of a Hq-dipeptide cotransporter in the
OTA transport route. OTA uptake was not saturated
in the micromolar range which is not a surprise
considering the K of 1.3 mM of the dipeptidem
w xcotransport system in MDCK cells 38 . We did not
use higher OTA concentrations to avoid unspecific
w xand toxic effects of OTA as described in 39 . The
reason why carnosine inhibits uptake and trans-
epithelial transport more effectively than glycylsarco-
sine remains unclear. But as transepithelial transport
is studied, different actions of the dipeptides on either
intracellular proteins or basolateral export is conceiv-
able.
At pH 7.4, OTA is transported at rates even lower
than those found in the presence of dipeptides at pH
6.0 and similar to those at 48C. This indicates that
besides the remaining activity of transporter, trans-
port of OTA is in addition a pH-dependent diffusion
 .simple or facilitated process on the apical mem-
brane. This is supported by the present finding that
the intracellular OTA concentration is high even after
incubation at 48C. OTA with a pK of 7.1 is lessa
charged and thus better membrane diffusible at pH
 .6.0 92% of total OTA uncharged than at pH 7.4
 .33% uncharged . Once inside the cell, OTA is
trapped by the more alkaline conditions which
 .recharge the OTA molecule 50% charged so that it
is less able to rediffuse across the membranes. As
 .expected, the transport of PAH pK 3.8 and ofa
FITC-Inulin did not show this pH dependence. Their
transport rates did not differ significantly at the two
pH values.
To which extent intracellular proteins interact with
this transport process is not known. Previous studies
in our laboratory demonstrated OTA binding to pro-
w xteins in both MDCK cell clones and in OK-cells 25 .
Therefore, a trapping effect of intracellular protein
cannot be excluded. Yet, metabolism of OTA by
these cells is very unlikely because we could not
w xdetect any known OTA metabolite 40–42 in the
HPLC analysis.
Transport of OTA by simple leakyness of the
monolayer or a transport via cell junctions can be
excluded because of its apical-to-basolateral unidirec-
tionality and because of its temperature and pH de-
pendence. Additionally, in the case of leakyness the
rate of PAH transport expressed as percent of total
amount should equal OTA transport. Also cell death
can be excluded because no increase in LDH activity
was detectable in the culture medium.
In conclusion our results show that OTA is trans-
ported across the apical membrane of MDCK cells by
non-ionic diffusion and possibly by a proton-coupled
dipeptide cotransporter. OTA leaves the cell by a
temperature-dependent process at the basolateral side.
Additionally, a reabsorption of OTA in the collecting
duct in vivo was demonstrated recently in our labora-
w xtory 43 so that the reabsorptive capability of the
collecting duct leads to a fatal cycling of OTA in the
body. Any OTA that is filtered can be reabsorbed in
the collecting duct and thus would contribute to the
( )G. Schwerdt et al.rBiochimica et Biophysica Acta 1324 1997 191–199 199
unusual long half live of OTA in the mammalian
body thus increasing the risk of severe diseases caused
by this mycotoxin.
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